Mr. Guise is a patent strategist with over 30 years of experience partnering with clients
to build, manage, and protect their global IP portfolios. With a doctorate in molecular
biology and immunology, he primarily helps start-up and middle-market pharmaceutical,
biotech, and medical technology companies build, enforce, and monetize their patent
portfolios. He also conducts and advises on IP-related transactional matters and
assessments, IP acquisition and licensing, non-infringement and validity opinions,
freedom to operate analyses, and invention records management plans.
Industry Experience
Mr. Guise’s technical experience enables him to truly understand the technologies his
clients invent so he can best protect them. He has worked with highly sophisticated
innovations and inventions for a wide range of biotechnology, medical diagnostics,
pharmaceutical, immunology, genetic engineering, genomics, proteomics, bioinformatics
software, agricultural biotechnology, and electronic hardware systems.
When needed, he has enforced IP through litigation, including pre-trial and trial
experience, interference proceedings, and litigation counseling. Mr. Guise is admitted
and has successfully tried cases in several U.S. district courts, courts of appeals, and the U.S. Patent and Trademark Office.
Honors/Distinctions
Recommended by The Legal 500 US Patents: Prosecution (2022-Present)
Recognized by The Best Lawyers in America for Biotechnology and Life Sciences (2022-
Present)
Named to the Managing IP List of IP STARS (2018)